Gonorrhea Figures
ShareCompartir
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
Figure 12. Gonorrhea — Rates of Reported Cases by Year, United States, 1941–2015
Figure 13. Gonorrhea — Rates of Reported Cases by Sex, United States, 2006–2015
Figure 14. Gonorrhea — Rates of Reported Cases by Region, United States, 2006–2015
Figure 15. Gonorrhea — Rates of Reported Cases by State, United States and Outlying Areas, 2015
Figure 16. Gonorrhea — Rates of Reported Cases by County, United States, 2015
Figure 17. Gonorrhea — Rates of Reported Cases by Age Group and Sex, United States, 2015
Figure 18. Gonorrhea — Rates of Reported Cases Among Women Aged 15–44 Years by Age Group, United States, 2006–2015
Figure 19. Gonorrhea — Rates of Reported Cases Among Men Aged 15–44 Years by Age Group, United States, 2006–2015
Figure 20. Gonorrhea — Rates of Reported Cases by Race/Ethnicity, United States, 2011–2015
Figure 21. Gonorrhea — Reported Cases Among Men by Reporting Source, United States, 2006–2015
Figure 22. Gonorrhea — Reported Cases Among Women by Reporting Source, United States, 2006–2015
Figure 23. Estimated Proportion of MSM, MSW, and Women Among Gonorrhea Cases by Jurisdiction, STD Surveillance Network (SSuN), 2015
Figure 24. Gonorrhea — Proportion of STD Clinic Patients Testing Positive by Age Group, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2015
Figure 25. Location of Participating Sentinel Sites and Regional Laboratories, Gonococcal Isolate Surveillance Project (GISP), United States, 2015
Figure 26. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Ceftriaxone Minimum Inhibitory Concentrations (MICs) (≥0.125 µg/ml) and Elevated Cefixime MICs (≥0.25 µg/ml), Gonococcal Isolate Surveillance Project (GISP), 2006–2015
Figure 27. Neisseria gonorrhoeae — Distribution of Azithromycin Minimum Inhibitory Concentrations (MICs) by Year, Gonococcal Isolate Surveillance Project (GISP), 2011–2015
Figure 28. Neisseria gonorrhoeae — Distribution of Isolates with Penicillin, Tetracycline, and/or Ciprofloxacin Resistance, Gonococcal Isolate Surveillance Project (GISP), 2015
Figure 29. Distribution of Primary Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP), 1988–2015
- Page last reviewed: October 17, 2016 (archived document)
- Content source: